Small Cell Lung Cancer Clinical Trials in Indianapolis, Indiana

4 studies are recruiting for small cell lung cancer in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

    Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess safety, tolerability, and change in disease activi…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Franciscan St. Francis Health /ID# 279788, Indianapolis, Indiana
    Locations
    63 in total
    Run by
    AbbVie

    See if you can join NCT07365241 on ClinicalTrials.gov

  2. A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after treatment with one platinum-based chemotherapy and anti-PD-L1/PD-1 immunotherapy agent. Up to one additional systemic anti-canc…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana
    Locations
    30 in total
    Run by
    Puma Biotechnology, Inc.

    See if you can join NCT06095505 on ClinicalTrials.gov

  3. Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

    This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana
    Locations
    3 in total
    Run by
    Indiana University

    See if you can join NCT05889546 on ClinicalTrials.gov

  4. MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

    This study has 2 cohorts: MOZART-ES cohort (for extensive-stage SCLC) and MOZART-LS cohort (for limited-stage SCLC). MOZART-ES cohort: Study treatment will consist of a platinum drug (carboplatin or cisplatin per investigator's choice) plus etoposide plus durvalumab plus monalizumab every 3 weeks f…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana
    Locations
    4 in total
    Run by
    Hirva Mamdani

    See if you can join NCT05903092 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.